Vitamin c infusion trial aims to boost blood cancer treatment
NCT ID NCT07283900
Summary
This study is testing whether adding high-dose vitamin C given through an IV can make the standard drug azacitidine work better for adults with higher-risk myelodysplastic syndrome (MDS), a type of blood and bone marrow disorder. The main goals are to see if the combination is safe and if it helps more patients respond to treatment. Researchers will enroll 38 participants who have not had much prior treatment for their MDS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.